Webb31 mars 2024 · Dec 2001 - May 20042 years 6 months. Houston, Texas Area. drawing on experience in purchasing, supply chain management, … Webb7 apr. 2024 · The rapid rise of COVID-19 cases in the U.S., though, throws Sage's ability to sell Zulresso in further doubt. "Zulresso is a hospital-based treatment. We are in competition for beds with COVID-19," said Mike Cloonan, Sage's chief business officer, on Tuesday's call.
Sage Therapeutics Announces Departure of Chief Operating Officer
WebbSage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. … Webb16 mars 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- SAGE Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating brain disorders, today announced that Mike Cloonan, Sage’s Chief Operating Officer, is leaving the company … normally connected cool offer
Coach and Business Mentor - Michael Cloonan - LinkedIn
WebbMichael Cloonan is the Chief Business Officer at SAGE Therapeutics. SAGE Therapeutics Chief Business Officer Board and Advisor Roles Number of Current Board … WebbMichael Cloonan is the Chief Business Officer at SAGE Therapeutics. SAGE Therapeutics Chief Business Officer Board and Advisor Roles Number of Current Board & Advisor Roles 1 Michael Cloonan is the Board Member at Sionna Therapeutics. Sionna Therapeutics Board Member Related Hubs Recent News and Activity Number of News … Webb24 apr. 2024 · Michael Cloonan will lead Sage’s Commercial, Portfolio and Program Mr. Cloonan comes to Sage from Biogen, where he worked for 14 years. Biogen, Mr. … normally concept